Clinical Trials for Triple Negative Locally Advanced Non-resectable Breast Cancer

Find clinical trials for triple negative locally advanced non-resectable breast cancer. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors

NCT ID: NCT06827613

This clinical trial is studying a new treatment called Invikafusp alfa, which is a special type of antibody designed to target certain cells in the body, in combination with another medication call...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Toronto, Ontario, Canada

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions